These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1977194)

  • 21. [The effect of basic therapy on the morphological picture of the rectal mucosa in patients with rheumatoid arthritis].
    Frizen BN; Panchenko KI; Vinogradov IuN
    Ter Arkh; 1995; 67(11):76-80. PubMed ID: 8571264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.
    van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Rustenburg F; Baggen JM; Verweij CL; Tak PP
    Ann Rheum Dis; 2008 Apr; 67(4):563-6. PubMed ID: 18042642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A trial of comparative effects of gold salts and D-penicillamine in rheumatoid arthritis].
    Nezić-Ivković J; Dürrigl T
    Reumatizam; 1978; 25(3):75-8. PubMed ID: 353935
    [No Abstract]   [Full Text] [Related]  

  • 24. [Gold preparations in the treatment of rheumatoid arthritis].
    Taukumova LA
    Ter Arkh; 2002; 74(2):82-7. PubMed ID: 11899836
    [No Abstract]   [Full Text] [Related]  

  • 25. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Basic therapy of rheumatoid arthritis].
    Z Gesamte Inn Med; 1977 Jul; 32(14):328-33. PubMed ID: 335680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of D-penicillamine on the immunological indices of rheumatoid arthritis patients].
    Sheĭtanov I
    Vutr Boles; 1990; 29(4):59-64. PubMed ID: 2281661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current concepts in clinical therapeutics: disease-modifying drugs for rheumatoid arthritis.
    Pugh MC; Pugh CB
    Clin Pharm; 1987 Jun; 6(6):475-91. PubMed ID: 3319362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in the level of unsaturated fatty acids in rheumatoid arthritis patients during treatment].
    Berezhnitskiĭ MN; Virstiuk NG
    Vrach Delo; 1990 Dec; (12):23-5. PubMed ID: 1982475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.
    Pincus T; Callahan LF
    Agents Actions Suppl; 1993; 44():67-75. PubMed ID: 8103964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenging the pyramid. A new look at terapeutic approaches for rheumatoid arthritis. Patient selection.
    Katz WA
    J Rheumatol Suppl; 1990 Nov; 25():39-41. PubMed ID: 1980315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New basic preparations with prolonged action in the treatment of rheumatoid arthritis].
    Tumanova IG; Sigidin IaA
    Ter Arkh; 1987; 59(4):80-3. PubMed ID: 2884735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Maintenance treatments of rheumatoid arthritis].
    Sany J
    Presse Med; 1990 Oct; 19(32):1479-81. PubMed ID: 1978309
    [No Abstract]   [Full Text] [Related]  

  • 36. Spontaneous synthesis of IgM rheumatoid factor by blood mononuclear cells from patients with rheumatoid arthritis: effect of treatment with gold salts or D-penicillamine.
    Olsen N; Ziff M; Jasin HE
    J Rheumatol; 1984 Feb; 11(1):17-21. PubMed ID: 6699830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis.
    Gerlag DM; Haringman JJ; Smeets TJ; Zwinderman AH; Kraan MC; Laud PJ; Morgan S; Nash AF; Tak PP
    Arthritis Rheum; 2004 Dec; 50(12):3783-91. PubMed ID: 15593225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A long-term clinical analysis of the rheumatoid patients treated by a combination of GST and CCA].
    Minami M; Kaneda K
    Ryumachi; 1995 Oct; 35(5):780-91. PubMed ID: 8594657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial.
    Häuselmann HJ; Caravatti M; Seifert B; Wang K; Bruckner P; Stucki G; Michel BA
    Br J Rheumatol; 1998 Oct; 37(10):1110-7. PubMed ID: 9825751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.